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Long-term consumption of a high glycaemic index (GI) or glycaemic load (GL) diet may lead to chronic hyperinsulinaemia, which is a
potential risk factor for cancer. To date, many studies have examined the association between GI, GL and cancer risk, although results
have been inconsistent, therefore our objective was to conduct a systematic review of the literature. Medline and Embase were
systematically searched using terms for GI, GL and cancer to identify studies published before December 2007. Random effects meta-
analyses were performed for endometrial cancer, combining maximally adjusted results that compared risk for those in the highest
versus the lowest category of intake. Separate analysis examined risk by body mass index categories. Five studies examining GI and/or
GL intake and endometrial cancer risk were identified. Pooled effect estimates for endometrial cancer showed an increased risk for
high GL consumers (RR 1.20; 95% CI: 1.06–1.37), further elevated in obese women (RR 1.54; 95% CI: 1.18–2.03). No significant
associations were observed for GI. Only two studies examined ovarian cancer and therefore no meta-analysis was performed, but
results indicate positive associations for GL also. A high GL, but not a high GI, diet is positively associated with the risk of endometrial
cancer, particularly among obese women.
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Ovarian and endometrial cancers are currently ranked 7th and 8th
of the most common female cancers worldwide, and typically
occur in developed countries (WCRF/AICR, 2007). Established risk
factors for both cancers include nulliparity and a long lifetime
exposure to oestrogen, that is for those who experience early
menarche and late menopause, whereas oral contraceptives are
known to be protective (Rieck and Fiander, 2006). A high body
mass index (BMI) has also been related to ovarian and endometrial
cancer risk (Olsen et al, 2007; WCRF/AICR, 2007), and risk of the
latter cancer can be exacerbated by polycystic ovarian syndrome in
overweight or obese women (Furberg and Thune, 2003). Recently,
it has been suggested that a moderately high carbohydrate, low
glycaemic index (GI) diet may prevent insulin resistance and
polycystic ovarian syndrome in women (Marsh and Brand-Miller,
2005).
Dietary GI is a method of classifying carbohydrate quality that
ranks foods according to their effect on the 2-h postprandial blood
glucose response (Jenkins et al, 1981). Food GI calculations are
usually based on portions containing 50g of carbohydrate however
an individual’s blood glucose, and hence insulin response, varies
after consuming differing amounts of carbohydrates. This led to
the introduction of the glycaemic load (GL) concept which
accounts for the GI and total carbohydrate content of a food and
is therefore considered a measure of carbohydrate quality and
quantity (Salmeron et al, 1997).
Long-term consumption of a high GI or GL diet may lead to
chronic hyperinsulinaemia, which has been shown to lower
insulin-like growth factor binding protein (IGFBP) concentrations,
thereby increasing insulin-like growth factor-1 (IGF-1) levels
(Augustin et al, 2002). Increased IGF-1 bioactivity inhibits
apoptosis, stimulates cell proliferation and sex steroid synthesis
and inhibits sex-hormone binding globulin synthesis, all of
which could be implicated in the development of endometrial
and ovarian cancer (Kaaks et al, 2002; Lukanova and Kaaks,
2005).
Consuming a low GI diet may also be beneficial in avoiding
weight gain and obesity (Brand-Miller et al, 2002), which is a
contributing factor in the development of hyperinsulinaemia and
excess oestrogen synthesis (Augustin et al, 2002). In turn,
hyperinsulinaemia, together with boosted plasma IGF-1 levels,
are thought to contribute to ovarian hyperandrogenism and a
subsequent reduction in endogenous progesterone production,
and it has been hypothesised that endometrial cancer risk is
increased in women whose oestrogen levels are insufficiently
counterbalanced by progesterone (Kaaks and Lukanova, 2001).
The epidemic of obesity, coupled with consumption of high GI
or GL diets, are typically associated with developed countries,
where the majority of ovarian and endometrial cancers are
diagnosed (WCRF/AICR, 2007). In view of the biologically
plausible mechanisms suggested above, it could be speculated that
dietary GI and GL are associated with endometrial and ovarian
cancer development and that BMI is a potential mediator of the
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seffect. To date, studies that have examined the association between
GI and GL intake and endometrial or ovarian cancer risk have
produced inconsistent results. A systematic review of the literature
would therefore be beneficial in order to create evidence-based
guidelines for public health.
The aim of the overall systematic review was to establish
whether dietary GI and GL are associated with risk of cancer, and
in this case, specifically endometrial and ovarian cancer and to
examine if risk varies by BMI.
MATERIALS AND METHODS
Study selection
Literature searches were conducted using Ovid Medline (US
National Library of Medicine, Bethesda, MD, USA), Medline In-
Process, Embase (Reed Elsevier PLC, Amsterdam, The Nether-
lands). The search strategy used medical subject heading (MeSH)
terms and keywords: glyc(a)emic index, glyc(a)emic load, blood
glucose, blood sugar(s) combined with diet, nutrition, dietary
carbohydrate(s), carbohydrate(s), dietary fibre/fibre, fibre/fibre,
dietary sugar(s), dietary sucrose and cancer, neoplasm(s),
neoplasia, adenoma, adenocarcinoma or carcinoma. Searches were
limited to studies conducted on humans published before
December 2007. Review publication types were removed but no
language restriction was specified. The identified articles were
independently screened by two reviewers (HGM and MMC) to
determine whether they met the inclusion criteria. To be included,
studies with endometrial or ovarian cancer as an outcome had to
have measured diet, and subsequently GI and/or GL in partici-
pants. The reviewers initially screened abstracts to remove
obviously irrelevant articles, and then the full text articles.
Discrepancies were resolved by discussion. Finally, the reference
lists of all included articles were examined.
Data extraction
Data extraction was conducted independently by two reviewers
(HGM and MMC) using piloted forms to record detailed
information on the study design, population characteristics,
dietary assessment methods used, confounders measured and,
finally, the results. Where essential information was missing,
authors were contacted personally. The reviewers applied the
Newcastle-Ottawa Quality Assessment Scale (http://www.lri.ca) to
all studies to consider factors such as selection of participants,
comparability of studies, follow-up and ascertainment of exposure
and outcome.
Statistical analysis
The association between cancer risk and GI or GL intake was
summarised by comparing the risk of cancer in the highest
reported category of GI (GL) intake to the lowest reported
category. Adjusted relative risk estimates (RRs) and their
corresponding standard errors were extracted from published
reports for each study. The RRs extracted referred to the top
quartile or quintile of intake compared with the lowest category of
intake. In case–control studies, adjusted odds ratios (ORs) were
used, and in cohort studies with variable follow-up: time adjusted
hazard rate ratios (HRs) were used, although in some studies these
were reported as RRs. Odds ratios and HRs should approximate
RRs as endometrial and ovarian cancers are rare (Symons and
Moore, 2002). Random effects models were used to calculate
pooled RRs, and the I
2 statistic (Higgins et al, 2003) was calculated
to quantify the degree of heterogeneity between studies. Random
effects models were deemed more appropriate than fixed effects
models because it was anticipated that there would be study
heterogeneity due to their observational nature. Study-specific
weights in the random effects model were calculated and scaled to
percentages. Publication and selection bias were investigated by
checking for asymmetry in the funnel plots of the study RRs
against the standard error of the logarithm of the RRs (Sterne and
Egger, 2001). The analysis was stratified by BMI, where this
information was provided and separate analyses were undertaken
for cohort and case–control studies. No meta-analysis was
conducted on ovarian cancer because of the small number of
studies published. Statistical analysis was conducted using
Intercooled STATA (version 9.2, StataCorp 2005, College Station,
TX, USA).
RESULTS
The search strategy results are shown in Figure 1. Five articles that
were identified investigated endometrial cancer (Folsom et al,
2003; Augustin et al, 2003a; Silvera et al, 2005; Larsson et al, 2007;
Cust et al, 2007a) and two that investigated ovarian cancer
(Augustin et al, 2003b; Silvera et al, 2007); the characteristics of
these studies are described in Table 1.
All studies principally employed either self-reported or inter-
viewer-administrated validated Food Frequency Questionnaires
(FFQs). Glycaemic index/GL values were primarily sourced from
International Tables (Foster-Powell and Miller, 1995; Foster-Powell
et al, 2002; Henry et al, 2005; University of Sydney website), with
some studies supplementing these with local sources (Augustin
et al, 2003b). All studies were conducted in Europe or North
America. Many potential confounders were adjusted for in
individual publications but these were inconsistent between
studies (Table 1). All adjusted for age and energy intake, whereas
adjustments for hormonal use, reproductive factors, menstrual
history, physical activity and other dietary variables including
alcohol intake varied between studies.
Endometrial cancer
Prospective cohorts accounted for four of the five studies
identified that examined endometrial cancer risk, all of which
incorporated adequate follow-up lengths, whereas the remaining
study was a hospital-based case–control study. Cohort studies
scored more highly on the quality scale compared with the case–
control study (Table 1). In all studies, cases were identified by
microscopic verification, linkage to cancer registries or self-report
and women who had undergone a hysterectomy were excluded.
The association between endometrial cancer and GI intake for
all five studies is shown in Figure 2. The combined adjusted RR of
endometrial cancer in the highest reported category of GI intake
413 excluded after screened by title, 
then abstract, then full text
4 excluded: multiple publications 
1 excluded: insufficient information on 
results (short correspondence) 
1 further paper identified from 
hand-searching reference lists 
461 publications identified from
electronic search strategy 
48 articles fulfilled inclusion 
criteria
44 articles included in overall
review of GI/GL and cancer 
5 endometrial cancer
2 ovarian cancer 
Figure 1 A flow diagram of study selection for GI/GL and endometrial
and ovarian cancer risk.
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sTable 1 Characteristics of studies included in systematic review of dietary glycaemic index, glycaemic load and risk of endometrial and ovarian cancer
Study–year–
Study
design
(mean
Controls/
cohort Diet
Quality
scale Median GI Median GL
Adjusted confounders
location follow-up) Cases size assessment score (IQ range) (IQ range) Age BMI Energy Hormon. Reprod. Menstr. Smoking PA Education Alcohol Fibre Diabetes Height
Endometrial
Cust et al
(2007a)
Europe
Prospective
cohort (6.4
years)
710 288428 Self-reported/
interviewed
FFQ and
24-h recall
9/9 56 (53–58) 117 (94–144) || | ## # || ## |
Larsson et al
(2007)
Sweden
Prospective
cohort
(15.6 years)
608 66651 Self-reported
67-item FFQ,
96-item FFQ
9/9 80 (74–86) 181 (155–210) || | | | | ## | #
Silvera et al
(2005)
Canada
Prospective
cohort
(16.4 years)
426 34391 Self-reported
86-item FFQ
9/9 73 (67–77) 148 (125–169) | | | | ||| | |
Folsom et al
(2003)
United States
Prospective
cohort ( )
a
415 23335 Self-reported
126-item FFQ
9/9 85 (81–89) 170 (147–193) || | | | | | |
Augustin et al
(2003a)
Switzerland/Italy
Hospital-
based case–
control
410 753 Interviewed
37-item FFQ
6/9 82
1 74
2 (70–88) 143
1 112
2 (108–214) || | | | |
Ovarian
Silvera et al
(2007)
Canada
Prospective
cohort
(16.4 years)
264 48776 Self-reported
86-item FFQ
9/9 77 (63–92) 148 (125–169) || | | | | | | |
Augustin et al
(2003b)
Italy
Hospital-
based case–
control
1031 2411 Interviewed
78-item FFQ
6/9 74 (70–78) 185 (147–234) || | | | | | | | |
FFQ¼Food Frequency Questionnaire; GI¼glycaemic index; GL¼glycaemic load; IQ¼Inter-quartile. Adjusted confounders: age; BMI¼body mass index; Energy¼energy intake; Hormon.¼hormone replacement therapy/oral
contraceptive use; Reprod.¼reproductive factors, e.g., parity, age at first birth; Menstr.¼menstrual history, e.g., age at menarche or menopause, menopausal status; Smoking; PA¼physical activity; Education; Alcohol intake;
Fibre¼Fibre intake; Diabetes¼History of diabetes.
#Indicates potential confounders that were tested but not included in the final model.
aTotal follow-up length 304558 women-years.
1Values from Swiss centre,
2Values from Italian
centre.
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scompared with the lowest reported GI category was 1.20 (95% CI:
0.95–1.51); however, there was evidence of statistical heterogeneity
(I
2¼62%, P¼0.03). The statistical heterogeneity was markedly
reduced (I
2¼0%, P¼0.69) when only the four cohort studies were
included in the analysis. There was little evidence of an association
between GI and endometrial cancer in these studies (RR 1.06; 95%
CI: 0.92–1.21).
The association between endometrial cancer risk and GL intake
for the five studies is shown in Figure 3. The combined adjusted RR
of endometrial cancer in the highest reported category of GL intake
compared with the lowest reported category of GL intake was 1.38
(95% CI: 1.08–1.77), but there was also evidence of marked
heterogeneity (I
2¼72%, Po0.01). Again, after the removal of the
case–control study, this heterogeneity was markedly reduced
(I
2¼0%, P¼0.80). The combined adjusted RR for the four
remaining cohort studies was still statistically significant showing
a 20% increased risk for endometrial cancer in women consuming a
high GL diet (RR 1.20; 95% CI: 1.06–1.37). The European
Prospective Investigation into Cancer and Nutrition (EPIC) study
also reported results of GI and GL intake as continuous variables
and showed an elevated risk of endometrial cancer of 1.40 (95% CI:
0.99–1.99) per 50Uday
 1 increments in GL. There was little
evidence of the presence of publication bias from examining funnel
plots for GI or GL and for endometrial cancer risk.
The association between GL and endometrial cancer after
stratification by BMI is shown in Figure 4. Additional information
by BMI stratification was sought from Cust et al (2007a), as this
study had indicated that the analysis had been conducted but not
published. Stratified analysis in the case–control study was only
shown for GI intake and additional information for GL was not
obtained due to variation in BMI cutoffs. There was little evidence
of an association between GL and endometrial cancer risk in the
normal weight women (RR 1.05; 95% CI: 0.86–1.28), some
evidence of increased risk in the overweight group (RR 1.27;
95% CI: 0.99–1.65) and strong evidence of a positive association in
obese women (RR 1.54; 95% CI: 1.18–2.03). There was little
evidence of heterogeneity between studies in the analysis stratified
by BMI. No significant associations were observed when GI and
endometrial cancer risk were investigated by BMI category, with
RRs of 1.03 (95% CI: 0.81–1.31), 1.42 (95% CI: 0.95–2.11) and 1.01
(95% CI: 0.71–1.43) detected for normal weight, overweight and
obese women, respectively.
Stratified analyses were performed according to other variables;
however, too few studies did so to enable robust investigation of
these by meta-analysis. Conflicting results indicated that the
association between GL and endometrial cancer risk may be
influenced by menopausal status (Silvera et al, 2005; Cust et al,
2007a), hormone replacement therapy (HRT) use (Augustin et al,
2003a; Folsom et al, 2003; Silvera et al, 2005), physical activity
levels (Silvera et al, 2005; Larsson et al, 2007) or diabetes history
(Folsom et al, 2003).
Ovarian cancer
One prospective cohort and one large case–control study of GI
and GL intake and ovarian cancer risk have been conducted to
Study  Relative
weight (%) 
Cohorts 
26 1.04 (0.84–1.28) Cust
24 1.00 (0.77–1.30) Larsson
13 1.47 (0.90–2.41) Silvera
21 1.05 (0.77–1.43) Folsom
1.06 (0.92–1.21)
Case–control
16 2.08 (1.37–3.15) Augustin
Overall 1.20  (0.95–1.51)  100 
∗ Test for heterogeneity  
2= 10.6, df= 4, P=0.03; I =62% (95% CI 0–86%).
2
1 1.5 2 2.5 3 0.75
Relative risk
  (95% CI) 
Figure 2 Meta-analysis of GI and endometrial cancer risk.
Relative risk Study
(95% CI) 
Relative
weight (%)
Cohorts 
24 ) 1 4 . 1 – 4 9 . 0 ( 5 1 . 1 Cust
21 ) 1 5 . 1 – 8 8 . 0 ( 5 1 . 1 Larsson
20 ) 4 8 . 1 – 1 0 . 1 ( 6 3 . 1 Silvera
19 ) 2 7 . 1 – 90 . 0 ( 4 2 . 1 Folsom
1.20 (1.06–1.37)
Case–control 
16 ) 9 1 . 4 – 9 7 . 1 ( 4 7 . 2 Augustin
Overall 1.38 (1.08–1.77) 100
3.5 2.5 2
.
1.5 1 0.75
∗ Test for heterogeneity  2  = 14.2, df= 4, P<0.01; I
2 =72% (95% CI 29–89%).
Figure 3 Meta-analysis of GL and endometrial cancer risk.
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sdate, with the latter study scoring slightly lower on the quality scale
(Table 1). The cohort recruited women as part of the Canadian
National Breast Screening programme, identifying cases by record
linkage to national cancer and mortality databases. Although the
Italian case–control study recruited hospital-based controls who
may not reflect the general population, cases were histologically
confirmed and any controls with modified dietary habits were
excluded. Notably, although the latter study failed to adjust for
BMI in their main analyses (Table 1), subgroup analyses results
were stratified by BMI in the original publication.
Both studies detected an increase in the risk of ovarian cancer in
the highest reported GI category compared with the lowest,
although only the case–control study detected this association as
significant (OR 1.65; 95% CI: 1.30–2.09). Stratified analyses within
the latter study demonstrated stronger associations between GI
and ovarian cancer risk in postmenopausal women (which was not
observed in the cohort study), overweight women, non-diabetics,
non-oral contraceptive users, parous women, alcohol consumers
and women without a family history of breast and/or ovarian
cancer. Highly significant increased risks were detected in both
studies of ovarian cancer and a high GL diet in all women (HR
2.15; 95% CI: 1.29–2.09 and OR 1.65; 95% CI: 1.30–2.09,
respectively). Both studies acknowledged that the majority of
cases identified were postmenopausal and associations tended
to be stronger for postmenopausal compared with that for
premenopausal women.
DISCUSSION
This is the first systematic review of the evidence to date on GI and
GL intake and endometrial cancer risk in relation to BMI and
provides evidence of a positive association between high GL diets
and endometrial cancer risk but little evidence of an association
for dietary GI intake. The finding that a high GL diet increases the
risk of endometrial cancer compared with a low GL diet
demonstrates the advantage of a meta-analysis because only one
of the individual studies reported statistically significant results,
although all studies showed associations in a positive direction. It
should be noted that some individual studies had a relatively
narrow range of GI and GL intakes, which could explain the lack of
statistically significant results observed in these studies. In the
cohort studies, comparing the highest versus the lowest category of
GL intake corresponded to an approximate difference of 50 GL
units (Folsom et al, 2003; Silvera et al, 2005, 2007; Cust et al, 2007a;
Larsson et al, 2007), whereas in the case–control studies this
observed difference was approximately 100 units (Augustin et al,
2003a,b). This could partly explain the stronger association
observed in the meta-analysis of endometrial cancer risk and GL
when the case–control study was included.
We did not observe an association between dietary GI and
endometrial cancer risk. This would suggest that endometrial
cancer risk is related to the actual blood glucose, and hence
insulin, demand induced by the consumption of normal portion
sizes of carbohydrates rather than the standard 50g used to
calculate GI values. Despite this, GI is still an important
contributor to the GL value of a food, and it would be preferable
to advise individuals to consume a diet composed of low GI/
moderate total carbohydrate content as opposed to high GI/low
total carbohydrate content to achieve a low dietary GL intake.
There is a paucity of research examining the association between
dietary factors and endometrial or ovarian cancer risk. Investiga-
tions of total carbohydrate or cereals have provided weak or null
associations (Jain et al, 2000; Trichopoulou et al, 2000). Identifying
a strong association for any modifiable dietary factor and
endometrial or ovarian cancer is therefore extremely valuable. In
addition, there is little evidence to suggest that a low GI diet may
have any accompanying adverse effects, and thus advising women
Normal weight
Cust 1.04 (0.79–1.38) 51
Larsson 0.94 (0.61–1.44) 22
Silvera 1.08 (0.68–1.71) 18
Folsom 1.28 (0.65–2.50) 9
Overall 1.05 (0.86- 1.28) 100
Test for heterogeneity  2= 0.6, df= 3, P=0.89; I2 =0% (95% CI 0–85%)
Overweight
Cust 1.34 (0.89–2.00) 40
Larsson 1.26 (0.76–2.10) 25
Silvera 1.40 (0.80–2.45) 21
Folsom 0.97 (0.48–1.93) 14
Overall 1.27 (0.99–1.65) 100
Test for heterogeneity  2= 0.8, df= 3, P=0.86; I2 =0% (95% CI 0–85%)
Obese
Cust 1.16 (0.73–1.85) 34
Larsson 1.57 (0.82–2.99) 17
Silvera 1.88 (1.08–3.29) 24
Folsom 1.88 (1.10–3.21) 25
Overall 1.54 (1.18–2.03) 100
 Test for heterogeneity  2=2.4,df= 3, P=0.49; I2 =0% (95% CI 0–85%)
1 0.5 0.66 1.5 2 2.5 3
Study Relative risk
(95% CI) 
Relative
weight (%) 
Figure 4 Meta-analysis of GL and endometrial cancer risk by BMI categories: normal weight (BMI o 25kg/m
2), overweight (BMI X25 and o30kg/m
2)
and obese (BMI X30kg/m
2).
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sto consume a low GL diet would seem a reasonable approach
(Colombani, 2004).
Previous reports have shown a linear dose–response relation-
ship between BMI and endometrial cancer risk (Jain et al, 2000;
Furberg and Thune, 2003; Schouten et al, 2004; Friedenreich et al,
2007). Our findings that a high GL diet increases the risk of
endometrial cancer as BMI increases, suggests that BMI may be an
effect modifier of the association between GL and endometrial
cancer, and that high GL diets may exaggerate endometrial cancer
risk in women who are more likely to be insulin resistant.
Additionally, a recent meta-analysis of 16 studies demonstrated
that diabetics have over twice the risk of developing endometrial
cancer compared with that of non-diabetics (Friberg et al, 2007).
Similar elevated risks of ovarian cancer incidence and mortality
were observed in a large UK cohort of diabetics compared with the
general population (Swerdlow et al, 2005). Consuming low GI
carbohydrates has been associated with improved glycaemic
control in diabetic patients compared with high GI diets in
randomised controlled trials (Brand-Miller et al, 2003). Other
subgroup analyses in the papers included in our review have
suggested that the association between GL and endometrial cancer
may be modified by diabetes, menopausal status, HRT use or
physical activity (Augustin et al, 2003a; Folsom et al, 2003; Silvera
et al, 2005; Cust et al, 2007a; Larsson et al, 2007). Unfortunately,
we were unable to perform meta-analyses on the basis of HRT use,
diabetes or physical activity as too few studies reported results by
these stratifications, and therefore no conclusions can be drawn
with respect to these variables.
Although the mechanisms are recognised to differ by cancer
site, the IGF system is often reported as the proposed mediator
between GI, and therefore potentially GL and cancer risk (Du et al,
2006). A validation study of the effect of GI on the insulin
response did report an overall 70% reduced insulin response
after consumption of a low GI food compared with a high GI
food (Brand-Miller et al, 2005). However, alterations to IGF-1
and IGFBP-3 levels were minimal following the low GI food
compared with the high GI food. Notably, this study was
conducted in lean young subjects, so the application of these
findings to obese people is currently unknown. Obese subjects are
known to have elevated circulating IGF-1 levels as a result of
overnutrition (Augustin et al, 2002), and it is therefore plausible
that a high GL diet in people with a higher BMI has a more
profound effect on IGF-1 levels. Unfortunately, studies that have
investigated the association between the IGF system and endo-
metrial and ovarian cancer risk have produced inconsistent
findings (Lukanova et al, 2004; Peeters et al, 2007; Tworoger
et al, 2007). Despite this, C-peptide, a marker of pancreatic
insulin production, has repeatedly been shown to be directly
related to endometrial cancer risk in well-designed studies
(Lukanova et al, 2004; Cust et al, 2007b), suggesting a key
role for hyperinsulinaemia. The majority of endometrial cancers
are oestrogen-related (WCRF/AICR, 2007), therefore hyperinsuli-
naemia induced by a habitually high GL diet may explain the
increased endometrial, and possibly ovarian, cancer risk by the
‘unopposed oestrogen’ hypothesis.
Oestrogen is a known mitogen, and overweight and obesity
could increase endometrial and ovarian cancer risk due to ovarian
hyperandrogenism (surplus ovarian androgen production), which
is promoted by hyperinsulinaemia, resulting in a subsequent
oestrogen excess derived from the aromatisation of androgens in
adipose tissue (Kaaks et al, 2002). In postmenopausal women, the
cessation of progesterone synthesis results in oestrogen concen-
trations being insufficiently counterbalanced, while in hyperinsuli-
naemic premenopausal women, absent ovulation and ensuing
progesterone deficiency may also enhance the mitogenic potential
of oestrogen (Kaaks and Lukanova, 2001; Kaaks et al, 2002). Others
have recognised that insulin levels per se cannot explain the
disparity in the observed risk between obesity and premenopausal
and postmenopausal breast cancer risk, whereas oestrogen
concentrations are well correlated (Key, 2001).
The precise mechanisms through which a high GL diet increases
endometrial, and potentially ovarian, cancer risk needs to be
clarified in further research that utilises independent biomarkers
such as C-peptide or components of the IGF system, in addition to
dietary exposure. The inclusion of biomarkers could help to
overcome the limitations associated with dietary GI and GL
evaluation. For example, GI and GL values apply only to single
foods, so when composite meals are consumed the ability to
predict insulinaemic responses from GI values has been ques-
tioned (Flint et al, 2004). Blood glucose and insulin concentrations
can also be influenced by other dietary components such
as protein and fats (Jenkins et al, 1984). Furthermore, the
studies in our systematic review used a mixture of glucose and
white bread reference values for GI and GL. The reproducibility of
GI and GL values and their application to different population
groups are often highlighted as important methodological issues
(Feskens and Du, 2006), and to our knowledge, the validity of
combining GI and GL results from different populations is
currently unknown.
Other limitations to individual study designs reported in this
review include the possibility of recall bias in case–control studies,
whereby cases recall their diet differently compared with healthy
controls (Augustin et al, 2003a,b). Self-administered FFQs were
used in all of the prospective cohorts, none of which were
specifically designed for assessing GI or GL intake. Food
Frequency Questionnaires are known to incorporate some dietary
measurement error, especially among overweight or obese
individuals but are the most convenient assessment tool available
for large-scale studies (Black et al, 1993). The FFQ employed in one
of the case–control studies was also relatively short, including only
37 items (Augustin et al, 2003a). Only two cohorts incorporated
repeat dietary measures (Cust et al, 2007a; Larsson et al, 2007), one
of which used a single 24-h recall in a stratified random sample of
participants in addition to an FFQ (Cust et al, 2007a), whereas the
other obtained dietary information using an FFQ at two different
time points (Larsson et al, 2007). Despite potential dietary
measurement error, it is unlikely that the women in these studies
were aware of any potential link between dietary GI or GL and
cancer at the time of participation, which ranged between the
1980s and 1990s.
Our meta-analysis of GI and GL intake and endometrial cancer
risk does have limitations. The overall results are based on only
five studies, and only four studies are included in the analysis
stratified by BMI. However, all studies incorporated a large
number of cases, particularly the EPIC study, which is a
multicentre investigation of the association between diet and
cancer risk in 10 European countries. Potential confounders such
as parity, hormonal use, age at menarche and age at menopause
were not universally adjusted for, which is not ideal when
combining results; however, age, energy intake and BMI were
adjusted for in all studies. We only compared low GI (GL) intake
with high GI (GL) intake in reported categorisations, which
differed from study to study. It is also difficult to determine with
certainty any effect of publication bias or heterogeneity in such a
small sample of studies, as indicated by the wide confidence
intervals shown in the I
2 test for heterogeneity. In addition, the
possibility of residual confounding cannot be ruled out.
Future well-designed studies or consortium-based analyses with
a large number of cases, and consequently, more power should be
conducted, particularly for the examination of interactions in
high-risk insulin-resistant population groups, that is overweight,
obese and sedentary women, to confirm our results. Further
research is required on the effects of a high GI or GL diet in
ovarian cancer, as our systematic review included only two studies,
both of which showed results similar to those seen for endometrial
cancer risk.
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sIn conclusion, consuming a high GL diet is associated with an
increased risk of endometrial cancer and risk is further increased
in obese women. Dietary GI does not appear to be related to
endometrial cancer risk. Further research is required on GI, GL
and ovarian cancer risk.
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